Karo Pharma (Formerly Known As Karo Bio AB)
Novum
S-141 57
Huddinge
Tel: 46-8-608-6000
Fax: +46 8 774 8261
Website: http://www.karobio.com/
Email: info@karobio.se
116 articles about Karo Pharma (Formerly Known As Karo Bio AB)
-
Avista Capital Partners To Sell Trimb To Karo Pharma
6/25/2019
The transaction is subject to regulatory review and anticipated to close before the end of 2019.
-
Karo Pharma: Interim Report January – September 2016
10/27/2016
-
Resolutions At Extraordinary General Meeting In Karo Pharma On July 21 2016
7/22/2016
-
Resolutions At Extraordinary General Meeting In Karo Pharma On July 21 2016
7/21/2016
-
Karo Pharma: Interim Report January – June 2016
7/15/2016
-
Notice Of Extraordinary General Meeting In Karo Pharma
6/28/2016
-
Notice Of Extraordinary General Meeting In Karo Bio AB (Publ)
2/12/2016
-
Karo Bio AB: Year-End Report 2015
2/12/2016
-
Change Of The Number Of Shares And Votes In Karo Bio AB
11/30/2015
-
Karo Bio AB Acquires Over 90 Per Cent of MedCore
10/28/2015
-
Change Of The Number Of Shares And Votes In Karo Bio AB
7/31/2015
-
Karo Bio AB: Interim Report January-June 2015
7/10/2015
-
Change Of The Number of Shares And Votes In Karo Bio AB (Publ)
5/29/2015
-
Resolutions Adopted By The Extraordinary General Meeting In Karo Bio AB Held On May 25, 2015
5/26/2015
-
Karo Bio AB Closes Acquisition Of Product For Treatment Of Common Cold Through A Directed Issue
4/27/2015
-
The Nomination Committee’s Proposals To The Annual General Meeting In Karo Bio AB
4/23/2015
-
Karo Bio AB Acquires Product For Treatment Of Common Cold
4/10/2015
-
Notice of Annual General Meeting In Karo Bio AB (publ)
3/30/2015
-
Karo Bio AB: Year-End Report 2014
2/13/2015
-
Organisational Changes In Karo Bio AB
2/4/2015